http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108084162-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate | 2018-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108084162-B |
| titleOfInvention | Dimethoxyanilinoacetamidobenzo[d]aza*ylquinazoline compounds and their preparation and application |
| abstract | The invention discloses a dimethoxyanilinoacetamidobenzo[d]azepine Quinazoline compounds and their preparation and application. Dimethoxyanilinoacetamidobenzo[d]azepines provided by the invention The quinazoline compounds have significant inhibitory activity against human breast cancer cell line MCF‑7, human lung cancer cell line A‑549, human promyelocytic leukemia cell line HL‑60, and human cervical cancer cell line Siha, and are expected to be The invention is applied to the preparation of medicines for treating human breast cancer, human lung cancer, human promyelocytic leukemia and human cervical cancer. The present invention provides the dimethoxyanilinoacetamidobenzo[d]azepine The preparation method of the quinazoline compound is simple, easy to operate, easy to obtain raw materials and low in production cost, and is suitable for practical use. |
| priorityDate | 2018-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 123.